Ilene Delgado, NP

Ilene Delgado practices at Holy Cross Health in Fort Lauderdale, Florida, part of Trinity Health.

Ilene Delgado's NPI, 1659040749, was assigned on September 10, 2021. Ilene Delgado holds Florida license APRN11002741.

Ilene Delgado's primary practice is Holy Cross Health, at 4725 N Federal Hwy, Fort Lauderdale, FL 33308 in Broward County. The practice phone is (954) 771-8000.

Ilene Delgado's primary practice is Holy Cross Health in Fort Lauderdale, Florida, part of Trinity Health. The medical group on file is Integral Rheumatology & Immunology Specialists. Dmand AI also links Ilene Delgado to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Ilene Delgado practices, 2 sites in all. Vendor and product names are available with a free account.

Nurse practitioner is Ilene Delgado's primary specialty in the NPI Registry, under taxonomy code 363L00000X. Ilene Delgado is licensed in Florida.

CMS data shows 72 Medicare services from Ilene Delgado across 1 procedure code in 2024, all of them office visits, for 62 Medicare patients. Medicare paid $6,316 for them. Every service was in an office.

CMS counts 62 Medicare patients who saw Ilene Delgado in 2024. The largest group is 65 to 74, with 27 patients. 75% of them have arthritis, and 75% have high blood pressure. 27% are also on Medicaid. Their average risk score is 1.65, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Ilene Delgado's median patient age at 66, with 85% women.

In 2024, Ilene Delgado wrote 1,190 Medicare Part D claims for 327 patients. 90% of them were for generic drugs. CMS names the drug for 1,019 of them, across 24 drugs with 11 or more claims each, at $564,110 in total drug cost.

Ilene Delgado accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 301 general payments to Ilene Delgado from 31 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 99% of the total. Janssen Pharmaceuticals, Inc paid the most, $748.